Lipiodol: From intrusion until exile from the tumor microenvironment
An editorial paper has been published in Oncoscience titled, "Lipiodol: from intrusion until exile from the tumor microenvironment."
Jan 8, 2024
0
0
An editorial paper has been published in Oncoscience titled, "Lipiodol: from intrusion until exile from the tumor microenvironment."
Jan 8, 2024
0
0
Immune checkpoint inhibitors (ICIs) are used to treat a variety of different cancers. ICIs are antibodies that sensitize the body's own immune system to detect and destroy tumors. However, ICIs are not effective in all patients, ...
Jan 3, 2024
0
50
A research perspective was recently published in Oncoscience, titled "Squamous cell carcinoma of the oral cavity—follow up treatment and distant metastatic behavior."
Dec 27, 2023
0
1
A study, published in the journal Gene Expression and led by Brady Jin-Smith from the Department of Pathology at Tulane University, focuses on ALDHs, a group of key enzymes that catalyze the irreversible oxidation of various ...
Dec 15, 2023
0
0
It's no secret that a high-fiber diet is good for you—just ask Google. Lots of research suggests that eating a high-fiber diet can lower your risk for certain cancers, but less is known about whether fiber can also help ...
Dec 13, 2023
0
0
A new study, published online ahead of print in Journal for ImmunoTherapy of Cancer on December 6, has identified a novel biomarker for ICIs in human cancers.
Dec 13, 2023
0
12
A study by the University of the Basque Country (UPV/EHU) uses game theory to establish that tumors with less cellular heterogeneity are more aggressive
Dec 4, 2023
0
0
Scientists from the Terasaki Institute for Biomedical Innovation (TIBI) have developed an injectable or catheter-administered hydrogel with enhanced capabilities for treating hepatocellular carcinoma (HCC), a deadly form ...
Nov 29, 2023
0
0
A study conducted at the University of Turku, Finland, shows that plixorafenib, a new drug developed for treating melanoma and lung cancer, may also stop the progression of cutaneous squamous cell carcinoma.
Nov 22, 2023
0
56
Lidocaine—often used as a numbing agent for outpatient medical procedures—activates certain bitter taste receptors through two unique mechanisms that result in cancer cell death, according to researchers from the Perelman ...
Nov 22, 2023
0
180